These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6134251)

  • 1. Benzodiazepine-opiate antagonist interactions and reward processes: implications for drug dependency.
    Cooper SJ
    Neuropharmacology; 1983 Apr; 22(4):535-8. PubMed ID: 6134251
    [No Abstract]   [Full Text] [Related]  

  • 2. Minireview. Benzodiazepine-opiate antagonist interactions in relation to feeding and drinking behavior.
    Cooper SJ
    Life Sci; 1983 Mar; 32(10):1043-51. PubMed ID: 6338330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA and endorphin mechanisms in relation to the effects of benzodiazepines on feeding and drinking.
    Cooper SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):495-503. PubMed ID: 6141600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide.
    Agmo A; Belzung C
    Neuropharmacology; 1998; 37(2):223-32. PubMed ID: 9680247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of chloroquine with benzodiazepine, gamma-aminobutyric acid and opiate receptors.
    Liu L; Katz Y; Weizman R; Rosenberg B; Pasternak GW; Gavish M
    Biochem Pharmacol; 1991 May; 41(10):1534-6. PubMed ID: 1850280
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking.
    Hyytiä P; Ingman K; Soini SL; Laitinen JT; Korpi ER
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):391-401. PubMed ID: 10551276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of opiate antagonists on food intake are stereospecific.
    Sanger DJ; McCarthy PS; Metcalf G
    Neuropharmacology; 1981 Jan; 20(1):45-7. PubMed ID: 6261182
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioral pharmacology of narcotic antagonists.
    Mello NK
    NIDA Res Monogr; 1978; (19):126-41. PubMed ID: 218104
    [No Abstract]   [Full Text] [Related]  

  • 9. Endogenous opioid peptides and regulation of drinking and feeding.
    Reid LD
    Am J Clin Nutr; 1985 Nov; 42(5 Suppl):1099-132. PubMed ID: 2865892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clorazepate affects cell surface regulation of delta and kappa opioid receptors, thereby altering buprenorphine-induced adaptation in the rat brain.
    Quentin T; Debruyne D; Lelong-Boulouard V; Poisnel G; Barre L; Coquerel A
    Brain Res; 2005 Nov; 1063(1):84-95. PubMed ID: 16269137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the opioid system in the anxiolytic effect of diazepam in mice.
    Tsuda M; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1996 Jun; 307(1):7-14. PubMed ID: 8831097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse.
    Griffiths RR; Weerts EM
    Psychopharmacology (Berl); 1997 Nov; 134(1):1-37. PubMed ID: 9399364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats.
    Overstreet DH; Knapp DJ; Breese GR
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1473-81. PubMed ID: 17624999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA and the behavioral effects of anxiolytic drugs.
    Sanger DJ
    Life Sci; 1985 Apr; 36(16):1503-13. PubMed ID: 2858804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tifluadom (KC 5103) induces suppression and latency changes on somatosensory evoked potentials which are reversed by opioid antagonists.
    Freye E; Hartung E; Schenk GK
    Life Sci; 1983; 33 Suppl 1():537-40. PubMed ID: 6319908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia.
    Cooper SJ; Jackson A; Kirkham TC
    Pharmacol Biochem Behav; 1985 Nov; 23(5):889-901. PubMed ID: 2867562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of opioid receptor sub-types in tifluadom-induced feeding.
    Jackson HC; Sewell RD
    J Pharm Pharmacol; 1984 Oct; 36(10):683-6. PubMed ID: 6150086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective interaction of homophtalazine derivatives with morphine.
    Fekete MI; Horváth K; Kedves R; Máté I; Székely JI; Szentkuti E
    Eur J Pharmacol; 1997 Jul; 331(2-3):175-83. PubMed ID: 9274977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventral tegmental site of opiate reward: antagonism by a hydrophilic opiate receptor blocker.
    Britt MD; Wise RA
    Brain Res; 1983 Jan; 258(1):105-8. PubMed ID: 24010170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of opioid antagonists on anticonvulsant and hypnotic activity of benzodiazepines.
    Fidecka S; Langwiński R
    Pol J Pharmacol; 1996; 48(4):409-14. PubMed ID: 9112681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.